(Q43863865)

27 November 2017

Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study (English)

1 reference

27 November 2017

DeAntoni EP

1

1 reference

27 November 2017

Crawford ED

2

1 reference

27 November 2017

Oesterling JE

3

1 reference

27 November 2017

Ross CA

4

1 reference

27 November 2017

Berger ER

5

1 reference

27 November 2017

McLeod DG

6

1 reference

27 November 2017

Staggers F

7

1 reference

27 November 2017

Stone NN

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

27 November 2017

1 reference

27 November 2017

48

1 reference

27 November 2017

234-239

1 reference

27 November 2017

2

1 reference

27 November 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Impact of prostate-specific antigen screening on the natural history of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Prostate cancer screening: what we know and what we need to know.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Second Stanford Conference on International Standardization of Prostate-Specific Antigen Immunoassays: September 1 and 2, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Relationship between prostate specific antigen, prostate volume and age in the benign prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Racial differences in adenocarcinoma of the prostate in North American men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Evaluation of age-specific normal ranges for prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Age-specific reference ranges for serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900091-X

7 January 2021

10.1016/S0090-4295(96)00091-X

Identifiers

DOI

1 reference

27 November 2017

1 reference